Clinical Trial Update: Defining Predictors of RT Response to Vedolizumab in IBD [Phase 4]

View source ↗

Summary

Phase 4 study update aimed at identifying predictors of response to vedolizumab in Crohn's disease affecting the small intestine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease of the Small Intestine

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Crohn Disease of Small Intestine | Phase 4 | Status: COMPLETED | Results posted: 2025-09-17